| RS2490436784 |
CEL
|
Health Risk |
Pathogenic |
Maturity-onset diabetes of the young type 8, Maturity-onset diabetes of the young type 8 |
| RS2490437438 |
SET
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2490437540 |
SET
|
Health Risk |
Pathogenic |
— |
| RS2490437710 |
CEL
|
Health Risk |
Likely pathogenic |
Maturity-onset diabetes of the young type 8, Maturity-onset diabetes of the young type 8 |
| RS2490440303 |
SET
|
Health Risk |
Pathogenic |
— |
| RS2490440555 |
BICD2
|
Health Risk |
Pathogenic |
— |
| RS2490442124 |
BICD2
|
Health Risk |
Pathogenic |
Spinal muscular atrophy with lower extremity predominance, Spinal muscular atrophy with lower extremity predominance |
| RS2490447870 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2490448712 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490448759 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490448849 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2490450597 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2490453128 |
BICD2
|
Health Risk |
Likely pathogenic |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures |
| RS2490455393 |
CHEK2
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2490457430 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2490457505 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2490459149 |
BICD2
|
Health Risk |
Likely pathogenic |
Spinal muscular atrophy, lower extremity-predominant |
| RS2490459662 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490459959 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490461316 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2490463730 |
PIGO
|
Health Risk |
Pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2490464967 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS2490470325 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS2490475612 |
PIGO
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS2490483708 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2490483848 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2490484546 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2490487316 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490487778 |
COL5A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490492592 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490496458 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
Pancytopenia-developmental delay syndrome, Pancytopenia-developmental delay syndrome |
| RS2490496771 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490499610 |
ADAMTS13
|
Health Risk |
Pathogenic |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS2490501351 |
COL5A1
|
Health Risk |
Pathogenic |
COL5A1-related disorder, COL5A1-related disorder |
| RS2490501961 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490502192 |
GALNT12
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2490507903 |
ADAMTS13
|
Health Risk |
Pathogenic |
— |
| RS2490509564 |
TG
|
Health Risk |
Likely pathogenic |
— |
| RS2490510639 |
COL5A1
|
Health Risk |
Likely pathogenic |
— |
| RS2490512531 |
ADAMTS13
|
Health Risk |
Conflicting classifications of pathogenicity |
Upshaw-Schulman syndrome, Upshaw-Schulman syndrome |
| RS2490513173 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490515237 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490515301 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490515378 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia, Citrullinemia |
| RS2490517188 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS2490517427 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490517429 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490517671 |
LMX1B
|
Health Risk |
Pathogenic |
LMX1B-related disorder, LMX1B-related disorder |
| RS2490517965 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490518161 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490518250 |
LMX1B
|
Health Risk |
Likely pathogenic |
— |
| RS2490518253 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490518285 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Inborn genetic diseases |
| RS2490518320 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490518360 |
LMX1B
|
Health Risk |
Pathogenic |
— |
| RS2490518599 |
LMX1B
|
Health Risk |
Likely pathogenic |
— |
| RS2490519684 |
SOHLH1
|
Health Risk |
Likely pathogenic |
Ovarian dysgenesis 5, Ovarian dysgenesis 5 |
| RS2490520604 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490520629 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490520787 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490521200 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490521936 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490522077 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490522246 |
VPS13B
|
Health Risk |
Likely pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490531268 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490531312 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490531358 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490531703 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490531804 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490532067 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia, Citrullinemia |
| RS2490535036 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490536330 |
COL5A1
|
Health Risk |
Likely pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS2490546368 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490546449 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490546871 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2490547878 |
COL27A1
|
Health Risk |
Likely pathogenic |
Steel syndrome, Steel syndrome |
| RS2490550913 |
COL27A1
|
Health Risk |
Likely pathogenic |
Steel syndrome, Steel syndrome |
| RS2490553149 |
ERCC6L2
|
Health Risk |
Pathogenic |
— |
| RS2490553259 |
ASS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Citrullinemia type I, Citrullinemia type I |
| RS2490553265 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490553577 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490555727 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2490556488 |
TG
|
Health Risk |
Pathogenic |
— |
| RS2490556729 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2490558508 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2490561736 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2490562078 |
ERCC6L2
|
Health Risk |
Likely pathogenic |
Pancytopenia-developmental delay syndrome, Pancytopenia-developmental delay syndrome |
| RS2490562660 |
ERCC6L2
|
Health Risk |
Pathogenic |
— |
| RS2490563082 |
TOR1A
|
Health Risk |
Likely pathogenic |
TOR1A-related disorder, TOR1A-related disorder |
| RS2490566466 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS2490567590 |
MUSK
|
Health Risk |
Pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 9 |
| RS2490569167 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2490581929 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS2490581988 |
ASS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrullinemia, Citrullinemia type I |
| RS2490582195 |
ASS1
|
Health Risk |
Pathogenic |
Citrullinemia, Citrullinemia |
| RS2490582225 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia, Citrullinemia |
| RS2490582353 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS2490583510 |
COL27A1
|
Health Risk |
Likely pathogenic |
— |
| RS2490585434 |
VPS13B
|
Health Risk |
Pathogenic |
Cohen syndrome, Cohen syndrome |
| RS2490588050 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |